Context Therapeutics Inc. buy BiotechBee
Start price
24.06.23
/
60%
€1.14
Target price
31.12.25
€3.00
Performance (%)
36.84%
Price
08.05.24
€1.56
Summary
This prediction is currently active. The BUY prediction by BiotechBee for Context Therapeutics Inc. has seen massive gains of 36.84%. This prediction currently runs until 31.12.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Context Therapeutics Inc. | 30.645% | 30.645% |
iShares Core DAX® | 3.178% | 0.980% |
iShares Nasdaq 100 | 2.972% | 0.925% |
iShares Nikkei 225® | 0.545% | -4.556% |
iShares S&P 500 | 2.367% | 0.833% |
According to BiotechBee what are the pros and cons of Context Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Context Therapeutics Inc. diskutieren
Buy mit Kursziel 3,0